@prefix bibo: <http://purl.org/ontology/bibo/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix massbank: <https://identifiers.org/massbank/> .
@prefix mbo: <http://www.massbank.jp/ontology/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix schema: <https://schema.org/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

massbank:MSBNK-UoB-XB000406 a mbo:MassSpectrum ;
    dcterms:creator "Tara J. Bowen, University of Birmingham" ;
    dcterms:date "2023-04-25"^^xsd:date ;
    dcterms:identifier "MSBNK-UoB-XB000406" ;
    dcterms:license <https://creativecommons.org/licenses/by/4.0/> ;
    dcterms:references [ a bibo:Article ;
            rdfs:label "Bowen, T.J.; Southam, A.D.; Hall, A.R.; Weber, R.J.M.; Lloyd, G.R.; Macdonald, R.; Wilson, A.; Pointon, A.; Viant, M.R. Simultaneously discovering the fate and biochemical effects of xenobiotics through untargeted metabolomics. Nat. Commun. (under review)" ] ;
    dcterms:rights " under CC BY" ;
    mbo:analytical_methods_and_conditions [ a mbo:AnalyticalMethods ;
            mbo:ac_instrument "Dionex Ultimate 3000 UHPLC Thermo Scientific; Q Exactive Focus Orbitrap MS Thermo Scientific" ;
            mbo:collision_energy "25,60,100% (stepped)" ;
            mbo:column_name "Accucore 150 Amide, 2.6um, 2.1x100mm, Thermo Scientific" ;
            mbo:flow_gradient "99/1 at 0 min, 99/1 at 1 min, 85:15 at 3 min, 50/50 at 6 min, 5/95 at 9 min, 5/95 at 10 min, 99/1 at 10.5 min, 99/1 at 15 min" ;
            mbo:flow_rate "0.5 mL/min" ;
            mbo:fragmentation_mode "HCD" ;
            mbo:instrument_type "LC-ESI-FT" ;
            mbo:ion_mode "POSITIVE" ;
            mbo:ms_type "MS2" ;
            mbo:resolution "17500" ;
            mbo:retention_time "0.093 min" ] ;
    mbo:compound [ a schema:chemicalsubstance ;
            rdfs:label "lansoprazole_BTP_M9" ;
            mbo:ch_compound_class "N/A; Biotransformation product" ;
            mbo:ch_exact_mass 5.45108e+02 ;
            schema:inChI "N/A" ;
            schema:molecularFormula "C22H22F3N3O8S" ;
            schema:name "lansoprazole_BTP_M9" ;
            schema:smiles "N/A" ] ;
    mbo:has_peak [ mbo:intensity 1.10544e+04 ;
            mbo:mz 1.350551e+02 ;
            mbo:peak_sequential_number 1 ;
            mbo:relative_intensity 339 ],
        [ mbo:intensity 1.15131e+04 ;
            mbo:mz 2.360352e+02 ;
            mbo:peak_sequential_number 2 ;
            mbo:relative_intensity 353 ],
        [ mbo:intensity 3.25402e+04 ;
            mbo:mz 3.700834e+02 ;
            mbo:peak_sequential_number 3 ;
            mbo:relative_intensity 999 ] ;
    mbo:mass_spectram_meta_data [ a mbo:MassSpectramMetaData ;
            mbo:base_peak 5.461154e+02 ;
            mbo:precursor_mz 5.461152e+02 ;
            mbo:precursor_type mbo:IT003 ] ;
    mbo:pk_num_peak 3 ;
    mbo:pk_splash "splash10-00dr-0339000000-70fd7ccf11fc55cef593" ;
    rdfs:comment "INTERNAL_ID 14288" ;
    skos:definition "lansoprazole_BTP_M9; LC-ESI-FT; MS2; CE: 25,60,100%; R=17500; [M+H]+" .

